Literature DB >> 15028557

Serial lung function and responsiveness in cystic fibrosis during early childhood.

Kim G Nielsen1, Tacjana Pressler, Bent Klug, Christian Koch, Hans Bisgaard.   

Abstract

In a 4-year prospective study, we evaluated specific airway resistance (sRaw) by whole-body plethysmography, respiratory resistance by the interrupter technique, and respiratory resistance and reactance at 5 Hz by the impulse oscillation technique combined with measurement of responsiveness to bronchodilators and cold air in 30 children (mean [range] age 5.7 [2 to 8] years) with cystic fibrosis (CF). Spirometry was done at school age. Mean sRaw was consistently abnormal: the mean z score (SD) was 2.52 (2.02) (p < 0.001) at the start and was unchanged 36 months later at 2.74 (2.02). Mean z score (SD) for FEV(1) at first satisfactory measurement, at a mean age (range) of 6.1 (4.9-7.5) years was -1.2 (1.2) and was further reduced to -1.85 (1.2) 4 years from inclusion at a mean age (range) of 9.9 (6.8-12) years. Neither respiratory resistance by the interrupter technique nor the impulse oscillation technique demonstrated consistent abnormal levels. Patients with CF as a group did not differ from healthy subjects in responsiveness to bronchodilators and cold air. sRaw may be a useful tool in CF during early childhood. Reduced lung function was documented from consistently abnormal levels of sRaw and FEV1 during the study. Bronchodilator responsiveness and response to cold air challenge were normal.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028557     DOI: 10.1164/rccm.200303-347OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

1.  Early pulmonary disease manifestations in cystic fibrosis mice.

Authors:  Rebecca J Darrah; Anna L Mitchell; Cara K Campanaro; Eric S Barbato; Paul Litman; Abdus Sattar; Craig A Hodges; Mitchell L Drumm; Frank J Jacono
Journal:  J Cyst Fibros       Date:  2016-05-24       Impact factor: 5.482

Review 2.  Lung Function Assessment by Impulse Oscillometry in Adults.

Authors:  Noemi Porojan-Suppini; Ovidiu Fira-Mladinescu; Monica Marc; Emanuela Tudorache; Cristian Oancea
Journal:  Ther Clin Risk Manag       Date:  2020-11-26       Impact factor: 2.423

Review 3.  Endpoints for clinical trials in young children with cystic fibrosis.

Authors:  Stephanie D Davis; Alan S Brody; Mary J Emond; Lyndia C Brumback; Margaret Rosenfeld
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 4.  Novel end points for clinical trials in young children with cystic fibrosis.

Authors:  Shannon J Simpson; Lauren S Mott; Charles R Esther; Stephen M Stick; Graham L Hall
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

5.  Assessment of bronchodilator responsiveness in preschool children using forced oscillations.

Authors:  Cindy Thamrin; Catherine L Gangell; Kanokporn Udomittipong; Merci M H Kusel; Hilary Patterson; Takayoshi Fukushima; André Schultz; Graham L Hall; Stephen M Stick; Peter D Sly
Journal:  Thorax       Date:  2007-04-05       Impact factor: 9.139

6.  Is Impulse Oscillometry System a Useful Method for the Evaluation and Follow-Up of Patients with Cystic Fibrosis?

Authors:  Gökçen Kartal Öztürk; Aykut Eşki; Figen Gülen; Esen Demir
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-03       Impact factor: 1.349

7.  Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis.

Authors:  Richard Kraemer; David N Baldwin; Roland A Ammann; Urs Frey; Sabina Gallati
Journal:  Respir Res       Date:  2006-11-30

Review 8.  Lung function tests to monitor respiratory disease in preschool children.

Authors:  Valentina Fainardi; Enrico Lombardi
Journal:  Acta Biomed       Date:  2018-06-14

9.  Scoring tools to monitor risk of disease progression in patients with cystic fibrosis.

Authors:  Márcio Vinícius Fagundes Donadio; Fernanda Maria Vendrusculo; Margarita Pérez-Ruiz
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

10.  Pulmonary function parameters and use of bronchodilators in patients with cystic fibrosis.

Authors:  Lucia Harumi Muramatu; Roberto Stirbulov; Wilma Carvalho Neves Forte
Journal:  J Bras Pneumol       Date:  2013 Jan-Feb       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.